| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue | 10,070,000 | 8,935,000 | 8,294,000 | | Cost of Revenue | 8,692,000 | 7,698,000 | 7,184,000 | | | Gross Profit | 1,378,000 | 1,237,000 | 1,110,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 602,000 | 571,000 | 525,000 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 776,000 | 666,000 | 585,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,000 | 53,000 | 122,000 | | Earnings Before Interest And Taxes | 781,000 | 716,000 | 695,000 | | Interest Expense | 78,000 | 90,000 | 92,000 | | Income Before Tax | 703,000 | 626,000 | 603,000 | | Income Tax Expense | 256,000 | 240,000 | 234,000 | | Minority Interest |
-
| (3,000) | (12,000) | | | | Net Income From Continuing Ops | 447,000 | 386,000 | 369,000 | | | Non-recurring Events | | Discontinued Operations | 5,000 | 30,000 | 22,000 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 452,000 | 416,000 | 391,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $452,000 | $416,000 | $391,000 |
|
1.48% Nasdaq 
Income Statement
